| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.32 | 0.07 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.081 | 0.07 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.07 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.076 | 0.07 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.07 |